Texas Capital Bancshares, Inc. (TCBIO)
Official siteFINANCIAL SERVICES • BANKS - REGIONAL • NASDAQ
Market Cap: $3.31B
Last updated: Nov 06, 2026 at 4:00 PM ET
Texas Capital Bancshares, Inc. (TCBIO) Financials: Revenue, Profit and Cash Flow
Texas Capital Bancshares reported revenue of $2.00B for the fiscal year ended Dec 31, 2025, up 13.5% from the year before. That year, net income was $330.24M with a net margin of 16.5%, operating cash flow was $360.15M and free cash flow was $347.58M. The quarter ended Sep 30, 2026 had revenue of $356.63M and net income of $103.70M.
Revenue and Margins
The operating margin was 21.6% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $623.59M, a compound annual rate of 13.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.00B | +13.5% | 60.1% | 21.6% | 16.5% |
| Dec 2024 | $1.76B | +75.4% | 49.2% | 16.3% | 4.4% |
| Dec 2023 | $1.00B | -13.4% | 100.0% | 24.6% | 18.8% |
| Dec 2022 | $1.16B | +31.8% | 100.0% | 31.8% | 28.7% |
| Dec 2021 | $879.30M | -11.2% | 100.0% | 38.4% | 28.9% |
| Dec 2020 | $989.72M | -5.7% | 100.0% | 9.3% | 6.7% |
| Dec 2019 | $1.05B | +15.9% | 100.0% | 38.8% | 30.8% |
| Dec 2018 | $905.88M | +14.4% | 100.0% | 40.1% | 33.2% |
| Dec 2017 | $791.58M | +26.9% | 100.0% | 36.4% | 24.9% |
| Dec 2016 | $623.59M | N/A | 100.0% | 33.6% | 24.9% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 326.1% from the year before. In the quarter ended Sep 2026, net income fell 1.4% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.00B | $1.76B | $1.00B | $1.16B | $879.30M | $989.72M | $1.05B | $905.88M | $791.58M | $623.59M |
| Cost of revenue | $798.15M | $895.25M | $787.80M | $334.48M | $77.75M | $446.09M | $460.59M | $336.33M | $161.97M | $140.59M |
| Gross profit | $1.20B | $865.35M | $1.00B | $1.16B | $879.30M | $989.72M | $1.05B | $905.88M | $791.58M | $623.59M |
| Operating income | $432.71M | $286.64M | $246.59M | $369.22M | $338.06M | $91.95M | $407.16M | $363.60M | $288.09M | $209.63M |
| Net income | $330.24M | $77.51M | $189.14M | $332.48M | $253.94M | $66.29M | $322.87M | $300.82M | $197.06M | $155.12M |
| EBITDA | $484.88M | $340.87M | $287.07M | $477.04M | $431.46M | $166.87M | $433.58M | $412.81M | $353.58M | $263.01M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $356.63M | $515.05M | $488.36M | $504.36M | $529.20M | $493.64M | $427.29M | $491.64M | $115.33M | $472.61M | $454.98M | $446.24M |
| Gross profit | N/A | $317.50M | $307.99M | $316.48M | $328.35M | $292.46M | $427.29M | $265.68M | $115.33M | $422.19M | $413.66M | $299.42M |
| Operating income | N/A | $112.00M | $94.42M | $132.28M | $137.78M | $102.19M | $422.28M | $93.52M | $99.59M | $64.17M | $43.36M | -$208.13M |
| Net income | $103.70M | $84.95M | $73.79M | $100.66M | $105.21M | $77.33M | $47.05M | $71.02M | -$61.32M | $41.66M | $26.14M | $15.84M |
Balance Sheet
As of Dec 2025, total debt of $950.58M exceeded cash and equivalents by $749.26M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $31.54B | $30.79B | $28.36B | $28.41B | $34.73B | $37.73B | $32.55B | $28.26B | $25.08B | $21.70B |
| Current assets | $2.10B | $244.06M | $3.43B | $9.49B | $12.09B | $13.12B | $5.38B | $28.05B | $24.92B | $21.60B |
| Cash and equivalents | $201.31M | $205.38M | $3.24B | $5.01B | $7.95B | $9.21B | $4.40B | $3.03B | $2.88B | $2.81B |
| Total liabilities | $27.91B | $27.42B | $25.16B | $25.36B | $31.52B | $34.85B | $29.72B | $25.76B | $22.87B | $19.69B |
| Short-term debt | $330.00M | $906.13M | $1.50B | $1.20B | $2.20B | $3.13B | $141.77M | $641.17M | $365.04M | $109.58M |
| Long-term debt | $620.58M | $660.35M | $859.15M | $931.44M | $3.13B | $395.90M | $395.54M | $395.17M | $394.81M | $394.45M |
| Shareholder equity | $3.63B | $3.37B | $3.20B | $3.06B | $3.21B | $2.87B | $2.83B | $2.50B | $2.20B | $2.01B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $32.35B | $33.91B | $33.49B | $31.54B | $32.54B | $31.94B | $31.38B | $30.73B | $31.63B | $29.85B | $29.18B | $28.40B |
| Total liabilities | $28.86B | $30.27B | $29.88B | $27.91B | $28.90B | $28.43B | $27.95B | $27.36B | $28.28B | $26.68B | $26.01B | $25.20B |
| Cash and equivalents | $195.09M | $3.49B | $2.70B | $201.31M | $212.44M | $2.69B | $201.50M | $205.38M | $297.05M | $2.91B | $3.32B | $3.24B |
| Shareholder equity | $3.49B | $3.65B | $3.61B | $3.63B | $3.64B | $3.51B | $3.43B | $3.37B | $3.35B | $3.18B | $3.17B | $3.20B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 96.5% of operating cash flow. Dividends came to 5.0% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $360.15M | $481.12M | $373.74M | $147.97M | $657.32M | $2.64B | -$240.27M | -$679.72M | $132.16M | -$726.29M |
| Capital expenditures | $12.57M | $64.84M | $16.38M | $11.27M | $4.13M | $2.80M | $16.65M | $7.65M | $12.27M | $2.18M |
| Free cash flow | $347.58M | $416.28M | $357.36M | $136.70M | $653.19M | $2.64B | -$256.92M | -$687.37M | $119.90M | -$728.47M |
| Dividends paid | $17.25M | $17.25M | $17.25M | $17.25M | $18.72M | $9.75M | $9.75M | $9.75M | $9.75M | $9.75M |
| Investing cash flow | -$1.85B | -$2.48B | -$1.76B | $3.31B | $1.23B | -$2.94B | -$2.28B | -$1.99B | -$3.22B | -$850.21M |
| Financing cash flow | $404.27M | $1.94B | -$387.67M | -$6.39B | -$3.15B | $5.08B | $3.86B | $2.85B | $3.15B | $2.62B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $212.61M | $103.49M | $87.53M | $132.16M | $164.63M | $63.00M | $368.00K | $34.01M | $333.25M | $33.64M | $80.22M | $76.70M |
| Capital expenditures | $0 | $1.36M | $1.36M | $12.91M | $4.95M | $5.54M | $2.42M | $57.44M | $15.19M | $22.20M | $20.04M | $3.73M |
| Free cash flow | $212.61M | $102.14M | $86.17M | $119.25M | $159.68M | $57.45M | -$2.05M | -$23.42M | $318.06M | $11.44M | $60.17M | $72.97M |
Frequently Asked Questions About TCBIO
What is Texas Capital Bancshares' annual revenue?
Texas Capital Bancshares reported revenue of $2.00B for the fiscal year ended Dec 31, 2025.
How fast is Texas Capital Bancshares' revenue growing?
Revenue was up 13.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 19.9%.
Is Texas Capital Bancshares profitable?
Yes. Texas Capital Bancshares reported net income of $330.24M for the fiscal year ended Dec 31, 2025, with a net margin of 16.5%.
How much free cash flow does TCBIO generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $360.15M minus capital expenditures of $12.57M produced free cash flow of $347.58M.
How much debt does Texas Capital Bancshares have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $620.58M, short-term debt of $330.00M and cash and equivalents of $201.31M.
TCBIO pages: Overview, Dividends, Financials